Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins
Jianan Gong(Walter and Eliza Hall Institute of Medical Research), David C.S. Huang(Indonesia International Institute for Life Sciences)
Cited by 4
Related Papers
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-x <sub>L</sub> , but not Bcl-2, until displaced by BH3-only proteins
|Genes & Development|2005|1.2k
Bim: a novel member of the Bcl‐2 family that promotes apoptosis
|The EMBO Journal|1998|1.2k
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
|Science Translational Medicine|2015|541